γδ T cells in cancer
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
With the promise of T cell-based therapy for cancer finally becoming reality, this Review focuses on the less-studied γδ T cell lineage and its diverse responses to tumours. γδ T cells have well-established protective roles in cancer, largely on the basis of their potent cytotoxicity and interferon-γ production. Besides this, recent studies have revealed a series of tumour-promoting functions that are linked to interleukin-17-producing γδ T cells. Here, we integrate the current knowledge from both human and mouse studies to highlight the potential of γδ T cell modulation to improve cancer immunotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“γδ T cells can have either protective roles or tumor-promoting functions in cancer; tumor-promoting activities of γδ T cells have been ascribed to distinct mechanisms in different types of cancers (Daley et al., 2016; Silva-Santos et al., 2015).”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Silva-Santos et al., 2015
Citations
Cites
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
The prognostic landscape of genes and infiltrating immune cells across human cancers
Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., Nair, V. S., Xu, Y., Khuong, A., Hoang, C. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3909 · Cited by 3,118
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Coffelt, S. B., Kersten, K., Doornebal, C. W., Weiden, J., Vrijland, K., Hau, C.-S., Verstegen, N. J. M., Ciampricotti, M., Hawinkels, L. J. A. C., Jonkers, J., et al. (2015) · Nature · doi:10.1038/nature14282 · Cited by 1,703
Mittal, D., Gubin, M. M., Schreiber, R. D., & Smyth, M. J. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.004 · Cited by 1,471
Immune adaptations that maintain homeostasis with the intestinal microbiota
Hooper, L. V., & Macpherson, A. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2710 · Cited by 1,454
Six-of-the-best: unique contributions of γδ T cells to immunology
Vantourout, P., & Hayday, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3384 · Cited by 1,232
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Research works printed but not linked: 1
- Gu, S., Nawrocka, W. & Adams, E. J. Sensing of pyrophosphate metabolites by Vγ9Vδ2 T cells. Front. Immunol. 5, 688 (2014).
Cited by
Items 401–500 of 593
Li, K., Lu, E., Wang, Q., Xu, R., Yuan, W., Wu, R., Lu, L., & Li, P. (2023) · Immunology · doi:10.1111/imm.13696 · Cited by 8
Wang, X., Jin, Y., Xu, L., Tao, S., Wu, Y., & Ao, C. (2024) · Cancer Control · doi:10.1177/10732748241274228 · Cited by 9
“12,13 γδ T cells have recently garnered attention as an ideal tool for cancer immunotherapy due to their antitumor function and role in immune surveillance.”
Approaches to investigate tissue-resident innate lymphocytes metabolism at the single-cell level
Corkish, C., de Aguiar, C. F., & Finlay, D. K. (2024) · Nature Communications · doi:10.1038/s41467-024-54516-3 · Cited by 10
Defying convention in the time of COVID-19: Insights into the role of γδ T cells
Sanz, M., Mann, B. T., Chitrakar, A., & Soriano-Sarabia, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.819574 · Cited by 8
Zhang, X., Chu, H., Cheng, Y., Ren, J., Wang, W., Liu, X., & Yan, X. (2023) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2022.8086 · Cited by 11
Facing challenges with hope: universal immune cells for hematologic malignancies
Wang, Y., Huang, R., Wang, Z., Xiong, J., Wang, X., & Zhang, X. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0759 · Cited by 8
Zhang, Y., Feng, Y., Zhao, Y., Feng, Y., Li, M., Wang, W., Ni, Z., Zhu, H., & Wang, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23552 · Cited by 8
“However, in addition to some activating receptors, including NKG2D, NCR, CD16, DNAM-1 and death ligands, which commonly exist on NK cells, gdT cells can also use their unique ( γδ ) TCR to distinguish normal cells from cancer cells and then selectively kill cancer cells [46].”
BackgroundWu, S., Chen, C., Tseng, P., Chiu, C., Lin, Y., & Lin, C. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28258 · Cited by 12
Yamamoto, R., Xu, Y., Ikeda, S., Sumida, K., Tanaka, H., Hozumi, K., Takaori‐Kondo, A., & Minato, N. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900111 · Cited by 8
Dangerous γδ T cells in aged mice
Prinz, I., & Sandrock, I. (2019) · EMBO Reports · doi:10.15252/embr.201948678 · Cited by 8
Regulation and Functions of Protumoral Unconventional T Cells in Solid Tumors
Barsac, E., Herbozo, C. D. A., Gonzalez, L., Baranek, T., Mallevaey, T., & Paget, C. (2021) · Cancers · doi:10.3390/cancers13143578 · Cited by 8
“UT cells constitutively express cytokine receptors and can rapidly respond to various cytokines produced by activated dendritic cells (DCs), macrophages, neutrophils, epithelial/endothelial/stromal cells or infected/tumor cells, including IL-12, IL-1β, IL-18, IL-23, IL-7, IL-15 and type I IFNs (see [52,53,60,61] for r…”
BackgroundCismaru, C. A., Pîrlog, R., Călin, G. A., & Berindan‐Neagoe, I. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10428-7 · Cited by 8
The clinical relevance of unfolded protein response signaling in breast cancerPreprint
Oshi, M., Roy, A. M., Gandhi, S., Tokumaru, Y., Yan, L., Yamada, A., Endo, I., & Takabe, K. (2022) · Research Square · doi:10.21203/rs.3.rs-1480002/v1 · Cited by 8
Ali, A., Özdemirli, M., Hamilton, M. P., & Jain, M. D. (2026) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-026-01147-w · Cited by 8
γδ T cells: The potential role in liver disease and implications for cancer immunotherapy
Ren, H., Li, W., Liu, X., & Zhao, N. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0822-733rrr · Cited by 7
The capability of heterogeneous γδ T cells in cancer treatment
Yan, W., Chard, L. S., Lemoine, N. R., Wang, Y., Wang, Y., & Wang, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1285801 · Cited by 9
Wei, X.-Y., Tan, Y., & Zhou, G. (2024) · Inflammation Research · doi:10.1007/s00011-024-01870-z · Cited by 8
“IL-17-secreting γδ T (γδ T17) cells have been identified as potent pro-tumor effectors, whereas IFN-γ-producing γδ T (γδ T1) cells are mainly associated with anti-tumor functions [6, 45].”
Controversial role of γδ T cells in colorectal cancer
Yu, X., Wang, L., Niu, Z., & Zhu, L. (2024) · American Journal of Cancer Research · doi:10.62347/hwmb1163 · Cited by 7
Shahid, A. M., Vainchenker, W., & Constantinescu, S. N. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70700 · Cited by 7
The way of interaction between Vγ9Vδ2 T cells and tumor cells
Zhang, T., Wang, J., Zhao, A., Xia, L., Jin, H., Xia, S., & Shi, T. (2022) · Cytokine · doi:10.1016/j.cyto.2022.156108 · Cited by 7
Chen, X., Wang, Z., Zhou, Y., Ye, L., & Man, X. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1191057 · Cited by 10
“DETCs are believed to negatively regulate αβ T cell-induced inflammation, thus contributing to local immune surveillance and immunoregulation, whereas αβ T cells promote skin tumor responses (39).”
BackgroundTyrosine Kinase Inhibition Activates Intratumoral γδ T Cells in Gastrointestinal Stromal Tumor
Etherington, M. S., Hanna, A. N., Medina, B. D., Liu, M., Tieniber, A. D., Kwak, H. V., Tardy, K. J., Levin, L. I., Do, K. J., Rossi, F., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0061 · Cited by 8
Cunha, D., Neves, M., Silva, D., Silvestre, A. R., Borralho, P., Arrobas, F., Ribot, J. C., Ferreira, F., Moita, L. F., Soares‐de‐Almeida, L., et al. (2024) · Cells · doi:10.3390/cells13110964 · Cited by 8
Reviving human γδT cells from apoptosis induced by IL-12/18 via p-JNK inhibition
Song, Y., Teo, H. Y., Liu, Y., Zhang, X., Chen, J., Zhang, Y., & Liu, H. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.5ma0622-741r · Cited by 7
γδ T cell costimulatory ligands in antitumor immunity
McGraw, J. M., & Witherden, D. A. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00038 · Cited by 9
“Adapted from “γδ T cells in cancer [12]” by Silva-Santos B, Serre K, Norell H.”
Fernández, E. A., Mahmoud, Y. D., Veigas, F., Rocha, D., Balzarini, M., Luján, H. D., Rabinovich, G. A., & Girotti, M. R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/726562 · Cited by 7
“The relevance of this finding is supported by previous literature showing the cytotoxic potential of T-cells against tumor cells (Silva-Santos et al. 2015; Wu et al. 2017; Zou et al. 2017; Lo Presti et al. 2018; Zhao et al. 2018).”
ResultGamma Delta T Cells in the Tumour Microenvironment: A Double‐Edged Sword
Hayati, M. J., Khojini, J. Y., Khara, F., Heydari, A., Vousooghi, N., Abootorabi, S. M. S., Barkhordar, M., & Mousavi, M. J. (2025) · Immunology · doi:10.1111/imm.70035 · Cited by 8
Zhang, Y., Ru, N., Xue, Z., Gan, W., Pan, R., Wu, Z., Chen, Z., Wang, H., & Zheng, X. (2023) · Journal of bone oncology · doi:10.1016/j.jbo.2023.100506 · Cited by 6
“…that gamma delta T cells could directly target tumor cells through granule extravasation pathways, antibody-dependent cytotoxic effects, and secreted cytokines, as well as indirectly affect antitumor immunity by activating other immune cells and coordinating downstream immune responses [112,113].”
BackgroundLiang, S., Dong, T., Yue, K., Gao, H., Wu, N., Liu, R., Chang, Y., Hao, L., Hu, L., Zhao, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1009709 · Cited by 7
Feng, S., Yang, C., Wang, J., Fan, X., & Ying, X. (2023) · Technology and Health Care · doi:10.3233/thc-220738 · Cited by 6
“…infiltration is higher in the high-risk group and that γδ T-cells, with their abundant cytokine secretory capacity and non-major histocompatibility complex limiting antigen recognition, are important players in the anti-tumor response [65,66], and the treatment of HCC is given a new perspective.”
Development of novel avenues to overcome challenges facing CAR T cells
Kim, S., & Moon, E. K. (2017) · Translational research · doi:10.1016/j.trsl.2017.05.009 · Cited by 7
Yamashita, D., Shimada, K., Kohno, K., Kogure, Y., Kataoka, K., Takahara, T., Suzuki, Y., Satou, A., Sakakibara, A., Nakamura, S., et al. (2020) · Pathology International · doi:10.1111/pin.12950 · Cited by 6
Papadopoulos, G., Berland, R., Sunkavalli, A., Coats, S. R., Darveau, R. P., & Genco, C. A. (2020) · Infection and Immunity · doi:10.1128/iai.00335-20 · Cited by 8
Study, T. S. H. C., Muller, C. K. S., Spagnuolo, J., Audigé, A., Chancellor, A., Russenberger, D., Scherrer, A. U., Hoffmann, M., Kouyos, R. D., Battegay, M., et al. (2021) · Infectious Agents and Cancer · doi:10.1186/s13027-021-00365-4 · Cited by 6
Bordoni, V., Guarracino, F., Galaverna, F., Bertaina, V., Pira, G. L., Rosichini, M., Pitisci, A., Matusali, G., Maggi, F., Velardi, E., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024013902 · Cited by 5
“16 Evidence demonstrates that CMV-R induces V δ 1 T-cell expansion both in solid organ transplantation 17 and in haplo-HSCT 18 recipients.”
Kast, R. E. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47030153 · Cited by 5
Single-cell transcriptional analysis reveals allergen-specific signatures in human γδ T cells
Kearns, K., Lewis, S. A., Yu, E. D., Abawi, A., Wang, E. W., Maiche, S., Mondal, M., Vijayanand, P., Seumois, G., Peters, B., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.191359 · Cited by 5
γδ T Cells in Glioblastoma Multiforme: Novel Roles and Therapeutic Opportunities
Dieli, C., Maugeri, R., Corsale, A. M., Simone, M. D., Avellone, C., Dieli, F., Iacopino, D. G., Brunasso, L., Cannarozzo, A., Costanzo, R., et al. (2025) · Cancers · doi:10.3390/cancers17162660 · Cited by 5
“These cells can be activated us-ing PAgs—either naturally derived (e.g., isopentenyl-pyrophosphate (IPP)) or synthetic analogs (e.g., BrHPP)—or pharmacologically through nitrogen-containing bisphosphonates (N-BPs), such as zoledronic acid (ZOL) [43].”
Anderko, R. R., Bowman, A. E., Murthy, P., Murthy, P., Chopra, A., Tirukkovalur, N. V., Ceuppens, S., Paniccia, A., Lee, K. K. W., Mailliard, R. B., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-1110 · Cited by 5
A novel combination strategy for effectively targeting cancer stem‐like cells
Beavis, P. A., Petley, E. V., & Darcy, P. K. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.39 · Cited by 6
Zhou, S., Yang, Y., Jing, Y., & Zhu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1435635 · Cited by 6
Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography
Yu, L., Lv, X., Song, X., Shao, F., Ji, H., Zhang, Y., Qiao, P., Liu, Q., Xia, X., Lei, P., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05886-7 · Cited by 5
“γδ T cells are promising candidates for tumor immunotherapy because of their unique features including potent cytotoxicity against tumor cells, rapid interferon-γ production, high proliferation capacity, and non-MHC-restricted antigen recognition [7, 12, 13].”
BackgroundDevelopment of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia–Lymphoma
Nakashima, M., Tanaka, Y., Okamura, H., Kato, T., Imaizumi, Y., Nagai, K., Miyazaki, Y., & Murota, H. (2024) · Cells · doi:10.3390/cells13020128 · Cited by 5
Mechanisms and Applications of γδ T Cells in Anti-Tumor Immunity
Zhang, Y., Liu, J.-W., Yao, J., Yuan, N., & Xu, R. (2025) · Cancer Control · doi:10.1177/10732748251399242 · Cited by 5
Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells
Paniagua‐Herranz, L., Díaz‐Tejeiro, C., Sanvicente, A., Bartolomé, J., Nieto‐Jiménez, C., & Ocaña, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1432015 · Cited by 4
Modeling tumor relapse using proliferation tracing and ablation transgenic mouse
Zhao, C., Zheng, X.-N., Huang, H.-Y., & Tian, L. H. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00792-1 · Cited by 4
Single-cell atlas of the tumor immune microenvironment across syngeneic murine models
Wang, J., Jiang, B., Deng, M., Yan, H., Zhang, P., Jin, W., & Shen, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1676581 · Cited by 4
“This subset may promote tumor progression by recruiting pro-in fl ammatory or immunosuppressive myeloid cells (39).”
Developmental and Functional Assays to Study Murine and Human γδ T Cells
Ribot, J. C., Serre, K., & Silva‐Santos, B. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6548-9_18 · Cited by 4
Self-citationStudy on the Killing Effect of γδT Cells Activated by Rukangyin on Breast Cancer MDA-MB-231 Cells
Chen, Z., Zhao, Y., Li, X., & Wang, K. (2021) · Disease Markers · doi:10.1155/2021/5838582 · Cited by 4
“Activated γδT cells can exert their cytotoxic effects on tumor cells through a variety of ways and have good antitumor effects both in vivo and in vitro [17].”
RetractedHuman Glomerular Endothelial Cells Treated With Shiga Toxin Type 2 Activate γδ T Lymphocytes
Rosso, D. A., Rosato, M., Gómez, F. D., Álvarez, R. S., Shiromizu, C. M., Keitelman, I. A., Ibarra, C., Amaral, M. M., & Jancic, C. C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.765941 · Cited by 4
Unconventional Immunotherapies in Cancer: Opportunities and Challenges
Alturki, M., Alshehri, A. A., Aldossary, A. M., Fallatah, M., Almughem, F. A., Fayez, N. A., Majrashi, M. A., Alradwan, I. A., Alkhrayef, M. N., Alomary, M. N., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18081154 · Cited by 5
Casado‐Fernández, G., Cantón, J., Nasarre, L., Ramos-Martín, F., Manzanares, M., Sánchez-Menéndez, C., Fuertes, D., Mateos, E., Murciano-Antón, M. A., Pérez‐Olmeda, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1362621 · Cited by 4
Gamma-Delta T Cell Acute Lymphoblastic Leukemia: A Single-Center Experience
Paluri, R., Donnellan, W., Mineishi, S., & Wicker, J. (2016) · Global Journal of Cancer Therapy · doi:10.17352/gjct.000010 · Cited by 4
The function of MSP-activated γδT cells in hepatocellular carcinoma
Du, B., Yu, R., Geng, X., Li, Y., Liu, Y., Liu, S., Li, F., Yu, Q., Guo, Y., & Xi, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110893 · Cited by 3
Li, H.-K., Wu, T., Ru, Y., Kuo, Y., Lee, C.-Y., Leng, P.-J., Hsieh, Y.-C., Chiang, Y.-J., Cheng, Z.-F., Lin, Y., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010500 · Cited by 3
Xi, X., Deng, T., Qiu, F., Zhu, Y., Li, Y., Li, G., Guo, Y., & Du, B. (2022) · Immunological Investigations · doi:10.1080/08820139.2022.2155182 · Cited by 3
“γδT cells are important lymphocytes in antitumor immunosurveillance because of their MHC-unrestricted cytotoxic activity (Meraviglia et al. 2017; Silva-Santos et al. 2015). γδT cell-based immunotherapy exhibits potent MHC-unrestricted cytotoxic activity against various cancer cells in vitro without the help of MHC-I o…”
BackgroundInfluentialMetabolomics analysis reveals resembling metabolites between humanized γδ TCR mice and human plasma
Michael, H., Weng, G. W., Vallas, M. M., Lovos, D., Chen, E., Sheiffele, P., & Weng, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-81003-y · Cited by 3
Immunopipe: a comprehensive and flexible scRNA-seq and scTCR-seq data analysis pipeline
Wang, P., Yu, Y., Dong, H., Zhang, S., Sun, Z., Zeng, H., Mondello, P., Kocher, J., Wang, J., Asmann, Y. W., et al. (2025) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaf063 · Cited by 5
Antibody-like recognition of a γδ T cell receptor toward a foreign antigen
Rashleigh, L., Venugopal, H., Rice, M. T., Gunasinghe, S. D., Sok, C. L., Gherardin, N. A., Almeida, C. F., Rhijn, I. V., Moody, D. B., Godfrey, D. I., et al. (2025) · Structure · doi:10.1016/j.str.2025.07.006 · Cited by 4
Clonal expansion shapes the human Vδ1T cell receptor repertoire
Meraviglia, S., & Dieli, F. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.66 · Cited by 3
A Previously Unrecognized Granulomatous Variant of Gamma-Delta T-Cell Lymphoma
Pukhalskaya, T., Smoller, B. R., Menke, D. M., & Sokumbi, O. (2021) · Dermatopathology · doi:10.3390/dermatopathology8020027 · Cited by 3
Perspective Chapter: The Role of Interferon Gamma in Clinical Medicine
Rakityanskaya, I. A., Ts, R., Андреевна, К. А., Balasaniants, G. S., Каприн, А. Д., Fi, E., Kir’janova, V. V., Korzhenevskaja, T. B., Barbinov, D. V., Ignatovskij, A. V., et al. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105476 · Cited by 3
Liou, M.-L., Lahusen, T. J., Li, H., Xiao, L., & Pauza, C. D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1012051 · Cited by 3
Harnessing γδ T Cells as Natural Immune Modulators
Hedges, J. F., & Jutila, M. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811924-2.00046-8 · Cited by 3
Wang, J., Ling, S., Ni, J., & Wan, Y. (2022) · BMC Cancer · doi:10.1186/s12885-022-09662-6 · Cited by 6
“Several studies have indicated that γδ T cells with protumor activity serve as pivotal players in cancer development and anti-tumor responses [24, 25].”
BackgroundMechanisms and Functions of γδ T Cells in Tumor Cell Recognition
Tang, J., Wu, C., Na, J., Deng, Y., Qin, S., Zhong, L., & Zhao, Y. (2025) · Current Oncology · doi:10.3390/curroncol32060329 · Cited by 3
A Sandwich-like metabolic regulator activated γδ T cells for dual immunotherapy
Hou, H., Chu, X., Cheng, G.-D., Li, Z.-Y., Liu, Y., & Li, S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114473 · Cited by 2
Aging Reshapes γ/δ T‐Cell Immunity Through a Type I Interferon–Foxo1 Axis
Durand, A., Porte, S., Xing, E., Wu, C., Bon, A. L., Auffray, C., Lucas, B., & Martin, B. (2026) · Aging Cell · doi:10.1111/acel.70389 · Cited by 2
“While their function in cancer immunity varies depending on tumor type and microenvironment (Lafont et al. 2014; Coffelt et al. 2015; Silva-Santos et al. 2015), γ/δ T cells are known to detect cellular stress and contribute to tumor surveillance, as demonstrated in multiple murine models (Street et…”
Chen, L. K., He, Y., Su, H., Tian, X., Liao, H., Liu, D., Zhao, M., Sun, H., Qi, L., Cao, M., et al. (2026) · Liver Cancer · doi:10.1159/000550945 · Cited by 3
Schröter, P. E., Steppich, K., Carrera, L. F., Song, Z., Klein, S., Souleiman, R., Urbanek‐Quaing, M., Lietzau, A., Schnieders, A., Freyer, E., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-337640 · Cited by 2
Jeon, S., Han, A., Choi, Y. B., Lee, A. R., & Lee, J. Y. (2022) · International Journal of Stem Cells · doi:10.15283/ijsc22150 · Cited by 2
“Thus, γδ T cells are potent effector cells that can be used in the clinic, suggesting their function as adaptive immune cells (24).”
BackgroundNanotechnology-Based Bacterial Immunotherapy
Arya, R. K. K., Sati, D., Bisht, D., & Keservani, R. K. (2022) · Springer eBooks · doi:10.1007/978-981-19-2507-8_1 · Cited by 13
Guo, R., Zhang, J., Jiang, S., Lin, J., Zhang, F., Zhou, W., Guan, Z., Xiang, L., Han, X., Yang, Q., et al. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad009 · Cited by 3
Elmansorry, E. M. (2024) · AlQalam Journal of Medical and Applied Sciences · doi:10.54361/ajmas.2471019 · Cited by 2
Key actors in neuropathophysiology: The role of γδ T cells
Bulgur, D., Moura, R. M., & Ribot, J. C. (2024) · European Journal of Immunology · doi:10.1002/eji.202451055 · Cited by 3
“This marked the beginning of an era for γδ T cells in cancer research [64], opening the path to developing innovative settings for immunotherapy, with more than 20 clinical trials currently ongoing [65–67].”
Zhang, J., Liu, G., & Wang, W. (2025) · Discover Oncology · doi:10.1007/s12672-025-02114-0 · Cited by 2
Sanz, M., Mann, B. T., McMahon, E. K., Bosque, A., Simmens, S. J., & Soriano-Sarabia, N. (2025) · Molecular Therapy Oncology · doi:10.1016/j.omton.2025.200996 · Cited by 2
“22 11, 17 represents an advantage over other cell types To our knowledge, a comprehensive analysis to test the effect of different N-BPs in combination with other compounds and/or cytokines to selectively target the expansion of cytotoxic V δ 2 T cells with increased antitumor function is lacking.”
Application of mass cytometry in the immune microenvironment of breast cancer
Shang, Y., Pang, Y., Liu, Y., & Wang, W. (2025) · Medical Oncology · doi:10.1007/s12032-025-02770-w · Cited by 2
“Γδ T cells are a type of T cell with characteristics of both innate and adaptive immune responses, capable of producing pro-inflammatory cytokines and exerting cytotoxic effects [38, 39].”
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Phan-Lai, V. (2016) · Biomedical Research and Therapy · doi:10.7603/s40730-016-0016-6 · Cited by 2
“Classical T cells (alpha-beta), unlike gamma-delta T cells (Silva-Santos et al., 2015) and B cells, cannot detect soluble antigen.”
BackgroundTherapeutic strategies to reverse immunosuppressive breast cancer microenvironment
Tamkus, D. M., & Joginpally, T. (2016) · Oncology Discovery · doi:10.7243/2052-6199-4-1 · Cited by 3
Fuchs, O., & Athari, S. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80249 · Cited by 3
Isaeva, V. G., Grivtsova, L. Y., Zhovtun, L. P., Samborsky, S. M., & Falaleeva, N. A. (2022) · Advances in molecular oncology · doi:10.17650/2313-805x-2022-9-2-111-119 · Cited by 2
γδ T cells and IgE team up to prevent tumors
McGraw, J. M., & Havran, W. L. (2018) · Nature Immunology · doi:10.1038/s41590-018-0167-2 · Cited by 2
Chen, J., Yuan, Q., Guan, H., Sun, J., & Liu, K. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.106626 · Cited by 1
DeTemple, V. K., Ritter, C., Srinivas, N., Spassova, I., Gambichler, T., Hüning, S., Gräger, N., Gutzmer, R., Bröcker, E., Ugurel, S., et al. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.115054 · Cited by 1
Múnera‐Rodríguez, A. M., Leiva‐Castro, C., Chacón, P., Palomares, F., & López-Enríquez, S. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2025.03.006 · Cited by 2
Alonso-Agudo, T., Johansson, J., Ståhlberg, A., & Bagge, R. O. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1564333 · Cited by 2
Gamma delta (γδ) T cells: origin, phenotype, functions
Соколов, Д. И. (2025) · Medical Immunology (Russia) · doi:10.15789/1563-0625-gdt-3160 · Cited by 1
Lauruschkat, C. D., Görge, H., Knies, K., Weißbrich, B., Dölken, L., Köchel, C., Imhof, N., Huber, M., Hengel, H., Einsele, H., et al. (2025) · Haematologica · doi:10.3324/haematol.2025.288237 · Cited by 1
“19,27 This resulted in an increased V δ 2 – /V δ 2 + ratio, which may benefit anti-HCMV immunity.”
Bold, A., Gross, H., Bardenbacher, M., Holzmann, E., Knop, S. T., & Wilhelm, M. (2025) · Cells · doi:10.3390/cells14231917 · Cited by 1
“Their anti-tumor effects have been demonstrated in a comprehensive way in vitro and in vivo [1–4].”
GALE is a tumor-intrinsic checkpoint of Vγ9Vδ2 T cell-mediated killing
Shan, Z., Wang, D., Zheng, Z., Ye, Z., Mao, S., Xie, L., Li, Y., Guo, Y., Weng, L., Wu, Q., et al. (2026) · Nature Cancer · doi:10.1038/s43018-026-01249-5 · Cited by 1
Song, M.-Z., & Wang, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1848122 · Cited by 1
Advances and prospects in cell therapy for cancer: explorations from T cells to stem cells
Zi, G., Zhang, L., Zhou, L., Liu, X., Wang, L., Zhou, R., Zheng, P., Wei, J., Chen, X., & Wei, S. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02780-8 · Cited by 3
“192,193 This synergistic mechanism signi fi cantly reduces the risk of antigen escape — when tumor cells downregulate the expression of TCR-targeted antigens, they often simultaneously upregulate the expression of NKG2D ligands, allowing γδ T cells to still kill tumor cells via the innate immune…”
Allogeneic iPSC-derived γδT cells demonstrate antitumor efficacy against patient-derived tissues
Futai, R., Koyanagi‐Aoi, M., Nakahashi, A., Katsura, D., Horikawa, M., Horie, K., Kakeji, Y., Kodama, Y., & Aoi, T. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.103018 · Cited by 1
Dai, Y., Xie, Y., Ma, X., Zhang, D., Yang, J., Lin, K., Chen, A., & Qiang, W. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.07.034 · Cited by 1
“This attribute endows them with superior tissue penetration advantages in the treatment of solid tumors, such as colorectal and lung cancers 41 .”
KLF4-Mediated Plasticity of Myeloid-Derived Suppressor Cells (MDSCs)
Fan, D., RAYCHOUDHURY, S. S., & Ai, W. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.89151 · Cited by 1
γδT cells: alternative treasure in antitumor immunity
Zhang, X., Xu, Y., Chen, H., Zhang, J., & He, W. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00035 · Cited by 1
“The importance of γδT cells in immune surveillance has also been confirmed in multiple mouse models [8].”
BackgroundThe microbiota is a potential mediator of the crosstalk between γδ T cells and tumors
Wang, H., Li, J., He, Y., & Yin, J. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00036 · Cited by 1
“Different studies using different methods, such as flow cytometry or immunohistochemistry, to detect tumor-infiltrating γδ T cells have reported an association of γδ T cells with tumor progression or tumor regression or even a lack of correlation with prognosis [76].”
BackgroundMethodChen, X., Jiang, X., Lu, Y., Yao, Y., Lu, J., Zhi, Q., Lai, L., Liang, J., & Li, C. (2022) · PubMed · Cited by 1
Gamma Delta T Cells and Organ Transplantation: A Review of Recent Studies
Yegin, R., Ahmed, A., & Hekimoğlu, G. (2023) · Medical Records · doi:10.37990/medr.1293786 · Cited by 1
Metadata
- Authors
- Silva-Santos, B., Serre, K., & Norell, H.
- Affiliations
- University of Lisbon (PT)
- Corresponding author
- Serre, Karine
- Venue
- Nature reviews. Immunology
- Published
- 2015-10-09
- Volume
- 15
- Issue
- 11
- Pages
- 683-691
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2183777144
- Cited by
- 565
- References
- 95
- Citations by year
- 2026: 30 · 2025: 43 · 2024: 39 · 2023: 60 · 2022: 72 · 2021: 59 · 2020: 63 · 2019: 54 · 2018: 55 · 2017: 56 · 2016: 33
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- γδ T cells, cancer immunotherapy, tumour immunity, cytotoxicity, interferon-gamma, IL-17, T cell regulation
- MeSH terms
- Animals, Cytotoxicity, Immunologic, Humans, Neoplasms, T-Lymphocytes, Receptors, Antigen, T-Cell, gamma-delta, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.